Shree Ram Proteins reports standalone net loss of Rs 4.32 crore in the March 2025 quarter
30 - May - 2025 12:00 | 16 hours ago
Net Loss of Shree Ram Proteins reported to Rs 4.32 crore in the quarter ended March 2025 as against net loss of Rs 3.32 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 21.08 crore in the year ended March 2025 as against net loss of Rs 9.58 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 as against Rs 14.77 crore during the previous year ended March 2024.
Shree Ram Protiens has postponed the meeting of the Board of Directors which was scheduled to be held on 13 May 2025. The meeting will now be held on 26 May 2025.
Shree Ram Protiens has postponed the meeting of the Board of Directors which was scheduled to be held on 13 May 2025. The meeting will now be held on 26 May 2025.
Shree Ram Proteins reports standalone net loss of Rs 4.66 crore in the December 2024 quarter
04 - Feb - 2025 12:00 | 115 days ago
Net Loss of Shree Ram Proteins reported to Rs 4.66 crore in the quarter ended December 2024 as against net loss of Rs 4.58 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.
Shree Ram Proteins reports standalone net loss of Rs 4.32 crore in the March 2025 quarter
30 - May - 2025 12:00 | 16 hours ago
Net Loss of Shree Ram Proteins reported to Rs 4.32 crore in the quarter ended March 2025 as against net loss of Rs 3.32 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 21.08 crore in the year ended March 2025 as against net loss of Rs 9.58 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 as against Rs 14.77 crore during the previous year ended March 2024.
Shree Ram Protiens has postponed the meeting of the Board of Directors which was scheduled to be held on 13 May 2025. The meeting will now be held on 26 May 2025.
Shree Ram Proteins reports standalone net loss of Rs 4.66 crore in the December 2024 quarter
04 - Feb - 2025 12:00 | 115 days ago
Net Loss of Shree Ram Proteins reported to Rs 4.66 crore in the quarter ended December 2024 as against net loss of Rs 4.58 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.
Shree Ram Proteins reports standalone net loss of Rs 4.32 crore in the March 2025 quarter
30 - May - 2025 12:00 | 16 hours ago
Net Loss of Shree Ram Proteins reported to Rs 4.32 crore in the quarter ended March 2025 as against net loss of Rs 3.32 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 21.08 crore in the year ended March 2025 as against net loss of Rs 9.58 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 as against Rs 14.77 crore during the previous year ended March 2024.
Shree Ram Protiens has postponed the meeting of the Board of Directors which was scheduled to be held on 13 May 2025. The meeting will now be held on 26 May 2025.
Shree Ram Protiens has postponed the meeting of the Board of Directors which was scheduled to be held on 13 May 2025. The meeting will now be held on 26 May 2025.
Shree Ram Proteins reports standalone net loss of Rs 4.66 crore in the December 2024 quarter
04 - Feb - 2025 12:00 | 115 days ago
Net Loss of Shree Ram Proteins reported to Rs 4.66 crore in the quarter ended December 2024 as against net loss of Rs 4.58 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.
